Description: Sigyn Therapeutics, Inc. operates as a therapeutic technology company that treats inflammatory conditions by cytokine storm syndrome. It offers Sigyn Therapy, a blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Sigyn Therapeutics, Inc. was incorporated in 2019 and is based in San Diego, California.
Home Page: www.sigyntherapeutics.com
2468 Historic Decatur Road
San Diego,
CA
92106
United States
Phone:
619-353-0800
Officers
| Name | Title |
|---|---|
| Mr. James A. Joyce Ph.D. | Co-founder, Chairman & CEO |
| Mr. Craig P. Roberts | Co-founder, CTO & Director |
| Mr. Jeremy Ferrell CPA, M.B.A. | Chief Financial Officer |
| Ms. Charlene R. Owen | Director of Operations |
| Mr. Eric Lynam MS | Head of Clinical Affairs |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 39.0415 |
| Price-to-Sales TTM: | 114.9523 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 5 |